Peer review reports
From: Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitrostudy
| Original Submission |
| 23 Jun 2009 |
Submitted |
Original manuscript
|
| 24 Jun 2009 |
Author responded |
Author comments - Zhe Zhang
|
| Resubmission - Version 2 |
| 24 Jun 2009 |
Submitted |
Manuscript version 2
|
| Publishing |
| 24 Aug 2009 |
Editorially accepted |
|
| 24 Aug 2009 |
Article published |
10.1186/1741-7015-7-41
|
Learn about peer review
